Sen. Crapo: Senate Republicans - Unprecedented Drug Price Control Scheme Threatens Innovation, Future Drug Costs
September 15, 2022
September 15, 2022
WASHINGTON, Sept. 15 -- Sen. Mike Crapo, R-Idaho, ranking member of the Senate Finance Committee, issued the following news release and letter:
Senate Republicans, led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho), are expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' plans for . . .
Senate Republicans, led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho), are expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' plans for . . .